DK482685D0 - Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme - Google Patents

Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme

Info

Publication number
DK482685D0
DK482685D0 DK482685A DK482685A DK482685D0 DK 482685 D0 DK482685 D0 DK 482685D0 DK 482685 A DK482685 A DK 482685A DK 482685 A DK482685 A DK 482685A DK 482685 D0 DK482685 D0 DK 482685D0
Authority
DK
Denmark
Prior art keywords
micellular
tumors
chemotherapeutic agents
micellular particles
particles
Prior art date
Application number
DK482685A
Other languages
Danish (da)
English (en)
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Raymond Leo Teplitz
Lawrence Ernest Williams
George Wing-Yiu Tin
Original Assignee
Hope Nat Medical Center
Vestar Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/663,550 external-priority patent/US5441745A/en
Priority claimed from US06/663,503 external-priority patent/US5435989A/en
Application filed by Hope Nat Medical Center, Vestar Research Inc filed Critical Hope Nat Medical Center
Publication of DK482685D0 publication Critical patent/DK482685D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK482685A 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme DK482685D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/663,550 US5441745A (en) 1982-03-30 1984-10-22 Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US06/663,503 US5435989A (en) 1982-03-30 1984-10-22 Method of targeting a specific location in a body

Publications (1)

Publication Number Publication Date
DK482685D0 true DK482685D0 (da) 1985-10-21

Family

ID=27098764

Family Applications (2)

Application Number Title Priority Date Filing Date
DK482685A DK482685D0 (da) 1984-10-22 1985-10-21 Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
DK484585A DK167556B1 (da) 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK484585A DK167556B1 (da) 1984-10-22 1985-10-22 Anvendelse af en micellepartikelkomposition, hvori partiklerne i sig selv har indkapslet et kemoterapeutisk middel, til fremstilling af et intravenoest indgiveligt farmaceutisk praeparat til indfoerelse af partikelkompositionen og det kemoterapeutiske middel i tumorceller

Country Status (11)

Country Link
EP (1) EP0179444B1 (de)
JP (1) JPH0747533B2 (de)
KR (1) KR900004802B1 (de)
AT (1) ATE64298T1 (de)
CA (1) CA1298548C (de)
DE (2) DE3583204D1 (de)
DK (2) DK482685D0 (de)
HK (1) HK119993A (de)
IE (1) IE58659B1 (de)
LU (1) LU88811I2 (de)
NL (1) NL960020I1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5648532A (en) * 1993-06-03 1997-07-15 The Regents Of The University Of California Compositions for boron neutron capture therapy and methods thereof
JPH10513466A (ja) * 1995-02-09 1998-12-22 シェリング アクチェンゲゼルシャフト 脈管内空間を視覚化するための造影剤を含むリポソーム
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
JP2007512221A (ja) * 2003-11-21 2007-05-17 富士フイルム株式会社 疎水性キレート化合物を含有するリポソームを含む造影剤
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
WO2012066896A1 (ja) * 2010-11-19 2012-05-24 Kato Junji 組合わせ医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
JPS59122423A (ja) * 1982-12-28 1984-07-14 Green Cross Corp:The 制癌剤含有脂肪乳剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム

Also Published As

Publication number Publication date
IE58659B1 (en) 1993-11-03
DK484585A (da) 1986-04-23
DK167556B1 (da) 1993-11-22
DE3583204D1 (de) 1991-07-18
CA1298548C (en) 1992-04-07
EP0179444A2 (de) 1986-04-30
KR900004802B1 (ko) 1990-07-06
JPH0747533B2 (ja) 1995-05-24
IE852602L (en) 1986-04-22
EP0179444B1 (de) 1991-06-12
KR860003514A (ko) 1986-05-26
DK484585D0 (da) 1985-10-22
ATE64298T1 (de) 1991-06-15
EP0179444A3 (en) 1987-08-12
NL960020I1 (nl) 1996-11-01
JPS61158932A (ja) 1986-07-18
LU88811I2 (fr) 1996-11-05
DE19675031I2 (de) 2008-04-10
HK119993A (en) 1993-11-12

Similar Documents

Publication Publication Date Title
EP0430968A4 (en) Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
ES8304797A1 (es) "procedimiento para la preparacion de nuevas formas orales de dipiridamol, en forma de granulados, pastillas o tabletas".
AU5418486A (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
AU4515985A (en) New tetrapyrrole therapeutic agents
DE3853579D1 (de) Tri-azamakrozyklen und deren metall komplexe.
ES8500743A1 (es) Procedimiento para preparar formas de mopidamol como granulados, granulos o tabletas
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
DK484585A (da) Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse
WO1992017159A3 (en) Stabilized emulsion compositions for imparting an artificial tan to human skin
HUT39433A (en) Process for producing alpha-aryl-4-/4,5-anhydro-3,5-dioxo-1,2,4-triazin-2/3h/-yl/-phenylacetonitriles and pharmaceutical compositions containing them as active agents
ZA898866B (en) Bone marrow suppressing agents
GR80951B (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
ES8708220A1 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
BG103729A (en) New derivatives of carboxylic acids, their preparation and administration for cancer treatment
EP0652755A1 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin.
ATE70456T1 (de) Verwendung von micellaren partikeln zur herstellung von zusammensetzungen zum beschiessen von tumoren in menschen und deren verwendung.
DE3380166D1 (en) Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
EP0201005A3 (en) 99mtc(iii)myocardial imaging agents which are non-reducable in vivo
JOHNSON et al. 5 Histopathology and Histochemistry of Cutaneous Calciphylaxis
Semeykina et al. Appearance of the Na+‐motive terminal oxidase in Bacillus FTU grown under three different conditions lowering the Δ\̄gmH+ level
ATE16139T1 (de) Elektrolyt fuer bleiakkumulator und diesen elektrolyt enthaltender akkumulator.
Domańska‐Janik et al. Effects of anoxia and depolarization on the movement of carbon atoms derived from glucose into macromolecular fractions in rat brain slices
Abroyan Ion Microbeam Analysis of the Phase Composition of Thin Layers of Silicon Alloyed With Phosphorus by Ion Implantation
Ainsworth et al. LATE EFFECTS OF HIGH LINEAR-ENERCY-TRANSFER (LET) RADIATIONS
JPS5690015A (en) Preventive and remedy containing human ceruloplasmin as main component

Legal Events

Date Code Title Description
ATS Application withdrawn